News | November 23, 2024
Amalgamation of Gujarat Themis Biosyn with Themis Medicare
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The company has posted net profit of Rs. 59.16 crores for the Financial Year ended March 31, 2024
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
Subscribe To Our Newsletter & Stay Updated
